"Adenocarcinoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant epithelial tumor with a glandular organization.
| Descriptor ID |
D000230
|
| MeSH Number(s) |
C04.557.470.200.025
|
| Concept/Terms |
Adenocarcinoma- Adenocarcinoma
- Adenocarcinomas
- Adenoma, Malignant
- Adenomas, Malignant
- Malignant Adenoma
- Malignant Adenomas
Carcinoma, Granular Cell- Carcinoma, Granular Cell
- Carcinomas, Granular Cell
- Granular Cell Carcinoma
- Granular Cell Carcinomas
- Adenocarcinoma, Granular Cell
- Adenocarcinomas, Granular Cell
- Granular Cell Adenocarcinoma
- Granular Cell Adenocarcinomas
Adenocarcinoma, Tubular- Adenocarcinoma, Tubular
- Adenocarcinomas, Tubular
- Tubular Adenocarcinoma
- Tubular Adenocarcinomas
- Carcinoma, Tubular
- Carcinomas, Tubular
- Tubular Carcinoma
- Tubular Carcinomas
Carcinoma, Cribriform- Carcinoma, Cribriform
- Carcinomas, Cribriform
- Cribriform Carcinoma
- Cribriform Carcinomas
Adenocarcinoma, Basal Cell- Adenocarcinoma, Basal Cell
- Adenocarcinomas, Basal Cell
- Basal Cell Adenocarcinoma
- Basal Cell Adenocarcinomas
Adenocarcinoma, Oxyphilic- Adenocarcinoma, Oxyphilic
- Adenocarcinomas, Oxyphilic
- Oxyphilic Adenocarcinoma
- Oxyphilic Adenocarcinomas
|
Below are MeSH descriptors whose meaning is more general than "Adenocarcinoma".
Below are MeSH descriptors whose meaning is more specific than "Adenocarcinoma".
- Adenocarcinoma
- Adenocarcinoma in Situ
- Adenocarcinoma, Bronchiolo-Alveolar
- Adenocarcinoma, Clear Cell
- Adenocarcinoma, Follicular
- Adenocarcinoma, Mucinous
- Adenocarcinoma, Papillary
- Adenocarcinoma, Scirrhous
- Adenocarcinoma, Sebaceous
- Adrenocortical Carcinoma
- Carcinoid Tumor
- Carcinoma, Acinar Cell
- Carcinoma, Adenoid Cystic
- Carcinoma, Ductal
- Carcinoma, Endometrioid
- Carcinoma, Hepatocellular
- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma, Islet Cell
- Carcinoma, Lobular
- Carcinoma, Mucoepidermoid
- Carcinoma, Neuroendocrine
- Carcinoma, Renal Cell
- Carcinoma, Signet Ring Cell
- Carcinoma, Skin Appendage
- Cholangiocarcinoma
- Choriocarcinoma
- Cystadenocarcinoma
- Eccrine Porocarcinoma
- Paget Disease, Extramammary
- Pulmonary Adenomatosis, Ovine
This graph shows the total number of publications written about "Adenocarcinoma" by people in this website by year, and whether "Adenocarcinoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 36 | 15 | 51 |
| 1995 | 64 | 17 | 81 |
| 1996 | 52 | 17 | 69 |
| 1997 | 47 | 15 | 62 |
| 1998 | 54 | 18 | 72 |
| 1999 | 61 | 13 | 74 |
| 2000 | 55 | 26 | 81 |
| 2001 | 75 | 16 | 91 |
| 2002 | 79 | 16 | 95 |
| 2003 | 77 | 32 | 109 |
| 2004 | 62 | 33 | 95 |
| 2005 | 101 | 37 | 138 |
| 2006 | 103 | 24 | 127 |
| 2007 | 110 | 28 | 138 |
| 2008 | 122 | 28 | 150 |
| 2009 | 110 | 27 | 137 |
| 2010 | 96 | 29 | 125 |
| 2011 | 120 | 28 | 148 |
| 2012 | 126 | 28 | 154 |
| 2013 | 122 | 30 | 152 |
| 2014 | 109 | 23 | 132 |
| 2015 | 115 | 16 | 131 |
| 2016 | 91 | 19 | 110 |
| 2017 | 101 | 14 | 115 |
| 2018 | 93 | 19 | 112 |
| 2019 | 70 | 9 | 79 |
| 2020 | 86 | 5 | 91 |
| 2021 | 66 | 8 | 74 |
| 2022 | 74 | 2 | 76 |
| 2023 | 74 | 3 | 77 |
| 2024 | 41 | 8 | 49 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adenocarcinoma" by people in Profiles.
-
Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete Response. JCO Precis Oncol. 2024 Dec; 8:e2400288.
-
Genome-Derived Ampullary Adenocarcinoma Classifier and Postresection Prognostication. JAMA Surg. 2024 Dec 01; 159(12):1365-1373.
-
HSP90 inhibitor AUY922 suppresses tumor growth and modulates immune response through YAP1-TEAD pathway inhibition in gastric cancer. Cancer Lett. 2025 Feb 01; 610:217354.
-
Targeted and combination immunotherapies using biologics for gastric cancer: the state-of-the-art. Expert Opin Biol Ther. 2024 Oct; 24(10):1005-1015.
-
Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma. N Engl J Med. 2024 Sep 26; 391(12):1159-1162.
-
Health-related quality of life in patients with CLDN18.2-positive, locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma: results from the SPOTLIGHT and GLOW clinical trials. ESMO Open. 2024 Aug; 9(8):103663.
-
Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancreatic Adenocarcinoma: A Transatlantic Evaluation of Patients in North America, Germany, Sweden, and The Netherlands (GAPASURG). Ann Surg Oncol. 2024 Nov; 31(12):8327-8339.
-
Atlas of Metastatic Gastric Cancer Links Ferroptosis to Disease Progression and Immunotherapy Response. Gastroenterology. 2024 Dec; 167(7):1345-1357.
-
The Sequencing Conundrum in Localized Pancreatic Adenocarcinoma-Progress or Passive Acceptance? JAMA Oncol. 2024 Aug 01; 10(8):1036-1037.
-
Urachal and Nonurachal Adenocarcinomas of the Urinary Bladder: A Comprehensive Genomic Profiling Study. JCO Precis Oncol. 2024 Aug; 8:e2400200.